Sensitive data creates a challenge for marketers
Teva Neuroscience had a problem. In 2006, the pharmaceutical company was preparing to launch Azilect, a new Parkinson's disease treatment. But, with big-name brands already known in the marketplace, the company needed a pre-launch boost.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.